Salona Cotspin Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 23, 2025, 9:49 am

Quick Insight

Salona Cotspin Ltd, operating in the textiles-spinning-cotton blended industry, currently trades at a price of 240 with a market capitalization of 126 crore. The company's P/E ratio stands at 53.1, indicating a premium valuation. Despite a low ROE of 3.86% and ROCE of 7.41%, the OPM is at 4.05%. With a substantial promoter holding of 67.09% and negligible FII and DII ownership, public shareholders account for 32.91%. Salona Cotspin's balance sheet shows reserves of 77 crore and significant borrowings of 239 crore, resulting in a P/BV ratio of 1.49x and an ICR of 1.70x. Given the company's high P/E ratio and modest return metrics, investors should carefully evaluate its growth prospects and debt levels before making investment decisions.

Competitors of Salona Cotspin Ltd

All Competitor Stocks of Salona Cotspin Ltd

Quarterly Result

Last Updated: August 20, 2025, 4:10 am

Below is a detailed analysis of the quarterly data for Salona Cotspin Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 157.10 Cr.. The value appears strong and on an upward trend. It has increased from 147.79 Cr. (Mar 2025) to 157.10 Cr., marking an increase of 9.31 Cr..
• For Expenses, as of Jun 2025, the value is 147.44 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 141.81 Cr. (Mar 2025) to 147.44 Cr., marking an increase of 5.63 Cr..
• For Operating Profit, as of Jun 2025, the value is 9.66 Cr.. The value appears strong and on an upward trend. It has increased from 5.98 Cr. (Mar 2025) to 9.66 Cr., marking an increase of 3.68 Cr..
• For OPM %, as of Jun 2025, the value is 6.15%. The value appears strong and on an upward trend. It has increased from 4.05% (Mar 2025) to 6.15%, marking an increase of 2.10%.
• For Other Income, as of Jun 2025, the value is 0.04 Cr.. The value appears strong and on an upward trend. It has increased from -0.03 Cr. (Mar 2025) to 0.04 Cr., marking an increase of 0.07 Cr..
• For Interest, as of Jun 2025, the value is 5.44 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 5.12 Cr. (Mar 2025) to 5.44 Cr., marking an increase of 0.32 Cr..
• For Depreciation, as of Jun 2025, the value is 2.24 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2.31 Cr. (Mar 2025) to 2.24 Cr., marking a decrease of 0.07 Cr..
• For Profit before tax, as of Jun 2025, the value is 2.02 Cr.. The value appears strong and on an upward trend. It has increased from -1.48 Cr. (Mar 2025) to 2.02 Cr., marking an increase of 3.50 Cr..
• For Tax %, as of Jun 2025, the value is 24.26%. The value appears to be improving (decreasing) as expected. It has decreased from 96.62% (Mar 2025) to 24.26%, marking a decrease of 72.36%.
• For Net Profit, as of Jun 2025, the value is 1.53 Cr.. The value appears strong and on an upward trend. It has increased from -2.92 Cr. (Mar 2025) to 1.53 Cr., marking an increase of 4.45 Cr..
• For EPS in Rs, as of Jun 2025, the value is 2.91. The value appears strong and on an upward trend. It has increased from -5.55 (Mar 2025) to 2.91, marking an increase of 8.46.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: August 23, 2025, 2:09 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: June 16, 2025, 11:25 am

Below is a detailed analysis of the balance sheet data for Salona Cotspin Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 5.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 5.00 Cr..
• For Reserves, as of Mar 2025, the value is 77.00 Cr.. The value appears strong and on an upward trend. It has increased from 74.00 Cr. (Mar 2024) to 77.00 Cr., marking an increase of 3.00 Cr..
• For Borrowings, as of Mar 2025, the value is 239.00 Cr.. The value appears to be improving (decreasing). However, Borrowings exceed Reserves, which may signal higher financial risk. It has decreased from 257.00 Cr. (Mar 2024) to 239.00 Cr., marking a decrease of 18.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 33.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 27.00 Cr. (Mar 2024) to 33.00 Cr., marking an increase of 6.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 354.00 Cr.. The value appears to be improving (decreasing). It has decreased from 364.00 Cr. (Mar 2024) to 354.00 Cr., marking a decrease of 10.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 106.00 Cr.. The value appears strong and on an upward trend. It has increased from 70.00 Cr. (Mar 2024) to 106.00 Cr., marking an increase of 36.00 Cr..
• For CWIP, as of Mar 2025, the value is 18.00 Cr.. The value appears to be declining and may need further review. It has decreased from 36.00 Cr. (Mar 2024) to 18.00 Cr., marking a decrease of 18.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Assets, as of Mar 2025, the value is 230.00 Cr.. The value appears to be declining and may need further review. It has decreased from 257.00 Cr. (Mar 2024) to 230.00 Cr., marking a decrease of 27.00 Cr..
• For Total Assets, as of Mar 2025, the value is 354.00 Cr.. The value appears to be declining and may need further review. It has decreased from 364.00 Cr. (Mar 2024) to 354.00 Cr., marking a decrease of 10.00 Cr..

However, the Borrowings (239.00 Cr.) are higher than the Reserves (77.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Key Financial Ratios

After reviewing the key financial ratios for Salona Cotspin Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 5.95. This value is within the healthy range. It has decreased from 11.64 (Mar 24) to 5.95, marking a decrease of 5.69.
• For Diluted EPS (Rs.), as of Mar 25, the value is 5.95. This value is within the healthy range. It has decreased from 11.64 (Mar 24) to 5.95, marking a decrease of 5.69.
• For Cash EPS (Rs.), as of Mar 25, the value is 20.40. This value is within the healthy range. It has decreased from 24.38 (Mar 24) to 20.40, marking a decrease of 3.98.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 154.96. It has increased from 149.69 (Mar 24) to 154.96, marking an increase of 5.27.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 154.96. It has increased from 149.69 (Mar 24) to 154.96, marking an increase of 5.27.
• For Dividend / Share (Rs.), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 1. It has decreased from 1.00 (Mar 24) to 0.00, marking a decrease of 1.00.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 1,242.58. It has decreased from 1,355.36 (Mar 24) to 1,242.58, marking a decrease of 112.78.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 60.28. This value is within the healthy range. It has increased from 57.20 (Mar 24) to 60.28, marking an increase of 3.08.
• For PBIT / Share (Rs.), as of Mar 25, the value is 45.76. This value is within the healthy range. It has increased from 44.32 (Mar 24) to 45.76, marking an increase of 1.44.
• For PBT / Share (Rs.), as of Mar 25, the value is 10.39. This value is within the healthy range. It has decreased from 15.77 (Mar 24) to 10.39, marking a decrease of 5.38.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 5.88. This value is within the healthy range. It has decreased from 11.50 (Mar 24) to 5.88, marking a decrease of 5.62.
• For PBDIT Margin (%), as of Mar 25, the value is 4.85. This value is below the healthy minimum of 10. It has increased from 4.21 (Mar 24) to 4.85, marking an increase of 0.64.
• For PBIT Margin (%), as of Mar 25, the value is 3.68. This value is below the healthy minimum of 10. It has increased from 3.26 (Mar 24) to 3.68, marking an increase of 0.42.
• For PBT Margin (%), as of Mar 25, the value is 0.83. This value is below the healthy minimum of 10. It has decreased from 1.16 (Mar 24) to 0.83, marking a decrease of 0.33.
• For Net Profit Margin (%), as of Mar 25, the value is 0.47. This value is below the healthy minimum of 5. It has decreased from 0.84 (Mar 24) to 0.47, marking a decrease of 0.37.
• For Return on Networth / Equity (%), as of Mar 25, the value is 3.79. This value is below the healthy minimum of 15. It has decreased from 7.68 (Mar 24) to 3.79, marking a decrease of 3.89.
• For Return on Capital Employeed (%), as of Mar 25, the value is 15.46. This value is within the healthy range. It has increased from 14.42 (Mar 24) to 15.46, marking an increase of 1.04.
• For Return On Assets (%), as of Mar 25, the value is 0.88. This value is below the healthy minimum of 5. It has decreased from 1.68 (Mar 24) to 0.88, marking a decrease of 0.80.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.78. This value is within the healthy range. It has decreased from 0.96 (Mar 24) to 0.78, marking a decrease of 0.18.
• For Total Debt / Equity (X), as of Mar 25, the value is 2.89. This value exceeds the healthy maximum of 1. It has decreased from 3.22 (Mar 24) to 2.89, marking a decrease of 0.33.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.84. It has decreased from 2.28 (Mar 24) to 1.84, marking a decrease of 0.44.
• For Current Ratio (X), as of Mar 25, the value is 1.15. This value is below the healthy minimum of 1.5. It has decreased from 1.24 (Mar 24) to 1.15, marking a decrease of 0.09.
• For Quick Ratio (X), as of Mar 25, the value is 0.81. This value is below the healthy minimum of 1. It has decreased from 0.94 (Mar 24) to 0.81, marking a decrease of 0.13.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 1.98. This value is below the healthy minimum of 4. It has decreased from 2.12 (Mar 24) to 1.98, marking a decrease of 0.14.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 10.30 (Mar 24) to 0.00, marking a decrease of 10.30.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 4.86 (Mar 24) to 0.00, marking a decrease of 4.86.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 89.70 (Mar 24) to 0.00, marking a decrease of 89.70.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 95.14 (Mar 24) to 0.00, marking a decrease of 95.14.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 1.70. This value is below the healthy minimum of 3. It has decreased from 2.00 (Mar 24) to 1.70, marking a decrease of 0.30.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.17. This value is below the healthy minimum of 3. It has decreased from 1.40 (Mar 24) to 1.17, marking a decrease of 0.23.
• For Enterprise Value (Cr.), as of Mar 25, the value is 359.54. It has decreased from 421.12 (Mar 24) to 359.54, marking a decrease of 61.58.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.54. This value is below the healthy minimum of 1. It has decreased from 0.58 (Mar 24) to 0.54, marking a decrease of 0.04.
• For EV / EBITDA (X), as of Mar 25, the value is 11.19. This value is within the healthy range. It has decreased from 13.82 (Mar 24) to 11.19, marking a decrease of 2.63.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.18. This value is below the healthy minimum of 1. It has decreased from 0.22 (Mar 24) to 0.18, marking a decrease of 0.04.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 89.69 (Mar 24) to 0.00, marking a decrease of 89.69.
• For Price / BV (X), as of Mar 25, the value is 1.49. This value is within the healthy range. It has decreased from 2.07 (Mar 24) to 1.49, marking a decrease of 0.58.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.18. This value is below the healthy minimum of 1. It has decreased from 0.22 (Mar 24) to 0.18, marking a decrease of 0.04.
• For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has decreased from 0.03 (Mar 24) to 0.02, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness